BIT Capital’s Definium Therapeutics DFTX Stock Holding History

BIT Capital’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.03M	Sell	128,131 -149,380	-54%	-$3.69M	0.18%	45
2026 Q1	$5.24M	Buy	+277,511	New	+$4.71M	0.25%	43
2025 Q4	–	Sell	-2,245	Closed	-$26.5K	–	131
2025 Q3	$26.5K	Buy	+2,245	New	+$20.9K	﹤0.01%	109
2025 Q1	–	Sell	-63,405	Closed	-$441K	–	135
2024 Q4	$441K	Buy	+63,405	New	+$436K	0.04%	84
2022 Q1	–	Sell	-9,333	Closed	-$193K	–	173
2021 Q4	$193K	Hold	9,333	–	–	0.01%	108
2021 Q3	$326K	Hold	9,333	–	–	0.02%	86
2021 Q2	$483K	Buy	+9,333	New	+$490K	0.03%	79

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BIT Capital's DFTX Position: Q2 2026 in Review

BIT Capital reduced its Definium Therapeutics (DFTX) stake by 54% in Q2 2026, selling an estimated $3.69M and leaving 128,131 shares worth $6.03M. The position accounts for 0.18% of the portfolio, ranked #45.

BIT Capital first reported a position in DFTX in Q2 2021 and has held it in 7 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

BIT Capital held 128,131 shares of Definium Therapeutics worth $6.03M as of Q2 2026.
BIT Capital sold 149,380 Definium Therapeutics shares in Q2 2026, an estimated $3.69M.
Definium Therapeutics made up 0.18% of BIT Capital's portfolio in Q2 2026, its #45 holding.
BIT Capital first reported a position in Definium Therapeutics in Q2 2021 and has held it in 7 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on BIT Capital's 13F filing for Q2 2026, filed 12 Aug 2026.